Sign up for free insights newsletter
Integrated Diagnostics Holdings PLC

Integrated Diagnostics Holdings PLC

IDHCLondon Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

$0.55
-8.79%
End of day
Market Cap

$32.26B

P/E Ratio

0.18

Employees

6,309

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.08-1.340.433.43-0.170.52
Calmar-4.31-1.680.473.45-0.070.27
Sharpe-1.44-0.990.251.88-0.120.21
Omega0.580.811.101.361.021.05
Martin-7.92-2.711.018.70-0.101.22
Ulcer8.3018.4613.6911.7852.9423.70

Integrated Diagnostics Holdings PLC (IDHC) Price Performance

Integrated Diagnostics Holdings PLC (IDHC) trades on London Stock Exchange in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.55, down 8.79% from the previous close.

Over the past year, IDHC has traded between a low of $0.30 and a high of $0.79. The stock has gained 77.8% over this period. It is currently 31.0% below its 52-week high.

Integrated Diagnostics Holdings PLC has a market capitalization of $32.26B, with a price-to-earnings ratio of 0.18.

About Integrated Diagnostics Holdings PLC

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.

Company Info

Exchange
London Stock Exchange
Currency
USD

Financial Metrics

Revenue (TTM)
$6.76B
EBITDA
$2.22B
Profit Margin
17.82%
EPS (TTM)
0.03
Book Value
5.37

Technical Indicators

52 Week High
$0.84
52 Week Low
$0.28
50 Day MA
$0.64
200 Day MA
$0.54
Beta
0.28

Valuation

Trailing P/E
0.18
Forward P/E
12.89
Price/Sales
3.02
Price/Book
6.23
Enterprise Value
$317.29M